Anish Suri
President chez CUE BIOPHARMA, INC.
Fortune : 256 356 $ au 31/03/2024
Profil
Anish Suri is a President & Chief Scientific Officer at Cue Biopharma, Inc. He previously worked as a Senior Director at Janssen Immunosciences, Inc. from 2015 to 2018 and as an Assistant Professor at Washington University School of Medicine from 2006 to 2007.
Dr. Suri holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Angelo State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC.
0,30% | 06/03/2024 | 135 638 ( 0,30% ) | 256 356 $ | 31/03/2024 |
Postes actifs de Anish Suri
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | President | 07/10/2019 |
Anciens postes connus de Anish Suri
| Sociétés | Poste | Fin |
|---|---|---|
| Janssen Immunosciences, Inc. | Corporate Officer/Principal | 01/05/2018 |
| Washington University School of Medicine | Corporate Officer/Principal | 01/01/2007 |
Formation de Anish Suri
| Washington University in St. Louis | Doctorate Degree |
| Angelo State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Janssen Immunosciences, Inc. |
